These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24476082)

  • 1. Pharmacokinetics of human chorionic gonadotropin injection in obese and normal-weight women.
    Shah DK; Missmer SA; Correia KF; Ginsburg ES
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1314-21. PubMed ID: 24476082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women.
    Chan CC; Ng EH; Chan MM; Tang OS; Lau EY; Yeung WS; Ho PC
    Hum Reprod; 2003 Nov; 18(11):2294-7. PubMed ID: 14585876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin.
    Saal W; Glowania HJ; Hengst W; Happ J
    Fertil Steril; 1991 Aug; 56(2):225-9. PubMed ID: 1712735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration.
    Mannaerts BM; Geurts TB; Odink J
    Hum Reprod; 1998 Jun; 13(6):1461-4. PubMed ID: 9688371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
    Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M
    Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evidence for predominance of delta-5 steroid production in women with polycystic ovary syndrome.
    Rosencrantz MA; Coffler MS; Haggan A; Duke KB; Donohue MC; Shayya RF; Su HI; Chang RJ
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1106-13. PubMed ID: 21270326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
    Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
    J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial.
    Sills ES; Drews CD; Perloe M; Kaplan CR; Tucker MJ
    Fertil Steril; 2001 Aug; 76(2):397-9. PubMed ID: 11476796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle.
    Stelling JR; Chapman ET; Frankfurter D; Harris DH; Oskowitz SP; Reindollar RH
    Fertil Steril; 2003 Apr; 79(4):881-5. PubMed ID: 12749424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal rhythm of testosterone induced by human chorionic gonadotrophin (hCG) therapy in isolated hypogonadotrophic hypogonadism: a comparison between subcutaneous and intramuscular hCG administration.
    Jones TH; Darne JF; McGarrigle HH
    Eur J Endocrinol; 1994 Aug; 131(2):173-8. PubMed ID: 8075787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearance of exogenously administered human chorionic gonadotropin.
    Damewood MD; Shen W; Zacur HA; Schlaff WD; Rock JA; Wallach EE
    Fertil Steril; 1989 Sep; 52(3):398-400. PubMed ID: 2776893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
    Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
    Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional delayed puberty in males and hypogonadotropic hypogonadism: a reliable and cost-effective approach to differential diagnosis.
    Martin MM; Martin AL
    J Pediatr Endocrinol Metab; 2005 Sep; 18(9):909-16. PubMed ID: 16279369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term human chorionic gonadotropin-induced testosterone rise does not modify leptin levels in eugonadal men.
    Panidis D; Koliakos G; Kourtis A; Rousso D; Mavromatidis G; Triantos A; Kalahanis I
    Gynecol Endocrinol; 2002 Feb; 16(1):75-81. PubMed ID: 11915586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulation after intravenous and intramuscular human chorionic gonadotropin.
    Fischer RA; Nakajima ST; Gibson M; Brumsted JR
    Fertil Steril; 1993 Sep; 60(3):418-22. PubMed ID: 8375519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG.
    Vuong LN; Pham TD; Ho VNA; Ho TM; Humaidan P; Andersen CY
    Front Endocrinol (Lausanne); 2020; 11():137. PubMed ID: 32265836
    [No Abstract]   [Full Text] [Related]  

  • 20. Human chorionic gonadotropin (HCG) treatment of obesity.
    Shetty KR; Kalkhoff RK
    Arch Intern Med; 1977 Feb; 137(2):151-5. PubMed ID: 836112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.